Biochemistry, Genetics and Molecular Biology
Mouse
97%
Cancer Cell
44%
Genetics
35%
Skeletal Muscle
29%
Drive
29%
Metabolic Pathway
29%
RNA Sequence
28%
Cardiac Muscle Cell
27%
Immune Checkpoints
27%
Mouse Model
23%
Gene Expression
21%
Carcinogenesis
20%
Transcription Factors
19%
Overall Survival
19%
T Cell
19%
CRISPR/Cas9
19%
Genetic Divergence
18%
Clinical Trial
17%
Digital Pathology
16%
RNA Sequencing
16%
Myogenesis
15%
T Cell Receptor
15%
Metabolomics
15%
Autophagy
14%
Body Mass
14%
Messenger RNA
14%
Prevalence
13%
Allele
13%
Nuclear Membrane
13%
Transcriptomics
13%
Genome-Wide Association Study
12%
KRAS
12%
Somatic Mutation
12%
Progenitor Cell
12%
Eicosanoid Receptor
12%
Morphology
11%
Metabolite
11%
Hepatocyte
11%
Transcriptome
11%
Germ Cell
11%
Germline
11%
Tumor Progression
11%
Dystrophin
10%
Heart Function
10%
RNA
10%
Adenine
10%
Exome
10%
Cell Death
10%
Reperfusion
10%
Fibroblast
9%
Sample Size
9%
RNA-binding Protein
9%
Methylation
9%
Oxidoreductase
9%
Zebra Fish
9%
Proteomics
9%
Forward Genetics
9%
Microbiome
9%
Whole Genome Sequencing
9%
Macrophage
9%
Exome Sequencing
9%
Enhancer Region
8%
PD-L1
8%
Nomenclature
8%
Kinase
8%
Phosphotransferase
8%
Promoter Region
8%
Oncogene
8%
Androgen Receptor
8%
Peptidase
8%
Artificial Intelligence
8%
Genetic Determinism
8%
RE1-silencing Transcription Factor
8%
Demethylase
8%
Coculture
8%
Ossification
8%
Cytometry by Time of Flight
8%
Stem Cell
8%
Protein Kinases
8%
Lymphocyte
8%
Gene Analysis
8%
Murine
8%
Induced Pluripotent Stem Cell
8%
Gene Expression Profiling
8%
Genotyping
8%
Dehydrogenase
7%
Exon Skipping
7%
Alpha Oxidation
7%
Single-Nucleotide Polymorphism
7%
Protein Expression
7%
Genome Editing
7%
Enzyme
7%
Magnetism
7%
Stromal Cell
7%
ARID1A
7%
Homeostasis
7%
Ectopic Expression
7%
Alternative Splicing
7%
Wart Virus
7%
Gene Fusion
7%
Medicine and Dentistry
Neoplasm
100%
Malignant Neoplasm
58%
Lung Cancer
54%
Bariatric Surgery
43%
Disease
33%
Non Small Cell Lung Cancer
26%
Pediatrics
25%
Base
25%
Clear Cell Renal Cell Carcinoma
24%
Tumor Microenvironment
24%
COVID-19
23%
Rhabdomyosarcoma
21%
Image Analysis
20%
Lung Adenocarcinoma
20%
Clustered Regularly Interspaced Short Palindromic Repeat
20%
Immune Checkpoint Inhibitor
19%
Overall Survival
19%
Cas9
18%
Germinoma
16%
Gene Expression
15%
Cardiac Muscle Cell
14%
Targeted Therapy
14%
Tumor Cell
14%
Magnetic Resonance Imaging
14%
Hepatocellular Carcinoma
13%
Metastatic Carcinoma
13%
Biological Marker
13%
Injury
13%
Telehealth
13%
Digital Pathology
12%
Transcription Factors
12%
Drive
12%
Atherosclerosis
12%
Small Cell Lung Cancer
12%
Receptor
12%
Adolescent
11%
Skeletal Muscle
11%
Cancer Cell
11%
Asthma
11%
Immune-Related Adverse Events
11%
Prevalence
11%
Macrophage
11%
Body Mass Index
10%
Radiation Therapy
10%
Immunotherapy
10%
Tumor Progression
9%
Endothelial Cell
9%
Cohort Analysis
9%
Dystrophin
9%
Heart Function
9%
Transcytosis
9%
RNA Sequence
8%
Morphology
8%
Stroma
8%
Squamous Cell Carcinoma
8%
Wart Virus
8%
Osteosarcoma
8%
Duchenne Muscular Dystrophy
8%
Scavenger Receptor BI
8%
Low-Density Lipoprotein
8%
Therapy Resistance
8%
Systematic Review
8%
Liver Cancer
8%
T Cell
8%
Xenograft
7%
Hazard Ratio
7%
Adenine
7%
Carcinogenesis
7%
Non-Small Cell Lung Cancer
7%
Lung Cancer Cell Line
7%
Catheter Ablation
7%
Programmed Death-Ligand 1
7%
Metabolite
7%
Kidney Cancer
7%
Reperfusion Injury
7%
Pathologist
6%
Heart Disease
6%
Gene Expression Profiling
6%
Lymphocyte
6%
Cancer
6%
Surgery
6%
Symptom
6%
In Vitro
6%
Epidermal Growth Factor Receptor
6%
Odds Ratio
6%
Breathing
6%
Logistic Regression Analysis
6%
Protein Expression
5%
Induced Pluripotent Stem Cell
5%
Autoantibodies
5%
Adeno-Associated Virus
5%
Exon Skipping
5%
Cancer Types
5%
Heart Failure
5%
Tumor Pathology
5%
Cancer Growth
5%
Angiogenesis
5%
Mammalian Target of Rapamycin
5%
Clinical Trial
5%
High Risk Population
5%
Keyphrases
Tumor
30%
Bariatric Surgery
28%
Metabolic Surgery
25%
Immune Checkpoint Inhibitors
24%
Rhabdomyosarcoma
22%
Non-small Cell Lung Cancer (NSCLC)
21%
Stem Cells
16%
Small Cell Lung Cancer
16%
In Cancer
15%
Lung Cancer
15%
Overall Survival
14%
Immune-related Adverse Events
13%
Skeletal muscle
12%
COVID-19
12%
Hepatocytes
10%
Immune Parameters
10%
Survival Outcomes
9%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
9%
Non-Hispanic White
9%
Ethnically Diverse
9%
Hepatocellular Carcinoma
9%
Tumor Cells
9%
Autoantibodies
9%
Base Editing
9%
Circular RNA
9%
Diverse Patients
9%
Tumor Microenvironment
9%
Patient-derived Xenograft
9%
Germ Cell Tumor
8%
Older Adults
8%
Cancer Cells
8%
Meta-analysis
8%
Gene Expression
8%
National Cancer Database
8%
Immunotherapy Toxicity
8%
Beclin-1
8%
JAK-STAT
8%
Multilineage
8%
Radiation Therapy
8%
Isometric Transformation
8%
Multi-disease
8%
Systemic Immune Response
8%
Targeted Therapy Resistance
8%
T-cell Receptor Repertoire
8%
Age-related Macular Degeneration
8%
Deep Learning
8%
Oncoprotein
8%
Liver Kinase B1 (LKB1)
8%
Patients with Obesity
8%
Asthma Treatment
8%
Adjusted Odds Ratio
7%
High-risk Human Papillomavirus (HR-HPV)
7%
Non-small Cell Lung Cancer Cells
7%
Asthma
7%
Hispanic
7%
Early-stage Lung Cancer
7%
Obesity
7%
Vulnerability
7%
Non-cell Autonomous
7%
Tumor Immunity
7%
Confidence Interval
7%
Clinical Outcomes
6%
Escherichia Coli
6%
Therapeutic Target
6%
United States
6%
Late-onset
6%
Liver
6%
T Cells
6%
Putative Drug Targets
5%
Exon Skipping
5%
Access to Care
5%
Oncogene
5%
Tumor Growth
5%
Transcription Factor
5%
Stimulator of Interferon Genes (STING)
5%
Human Genome
5%
Renal Cancer
5%
Whole Genome Sequencing
5%
Humanized Mice
5%
Large Cohort
5%
Pediatric Population
5%
Lung Cancer Cell Lines
5%
Antibiotics
5%
Ploidy
5%
Therapeutic Vulnerabilities
5%
Non-small Cell Lung Cancer Patients
5%
Autophagy-related Proteins
5%
Lineage Plasticity
5%
DNA Damage
5%
Adaptive Immune Response
5%
COVID-19 Pandemic
5%
Humanized Mouse Model
5%
Asthmatic children
5%
Histopathology Images
5%
Aberrations
5%